245 related articles for article (PubMed ID: 15617338)
21. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
[TBL] [Abstract][Full Text] [Related]
22. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
Dong Z; Shen H; Zhang FK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):129-31. PubMed ID: 17653313
[TBL] [Abstract][Full Text] [Related]
24. [Functional MRI in chronic liver disease of hepatitis B patients].
Wang K; Wang PJ; Zhao ZH; Wang Z; Xu SS; Liu WJ; Rui YP; Xue XY
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):590-6. PubMed ID: 16938171
[TBL] [Abstract][Full Text] [Related]
25. [Changes in the hemodynamic parameters of the portal vein and serum fibrosis markers in patients with chronic viral hepatitis B].
Yang YP; Zhan SL; Li YJ; Zhang W; Wang CW; Song XX
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):341-3. PubMed ID: 12390741
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic values of serum levels of HA, PC III, C IV and LN to the liver fibrosis in children with beta-thalassemia major].
Xu HG; Fang JP; Huang SL; Li HG; Zhong FY; Guo HX; Su H
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):603-6. PubMed ID: 14744384
[TBL] [Abstract][Full Text] [Related]
27. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
28. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.
Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagasawa M; Toyama T; Ozaki S; Naito M; Azuma M
Hepatology; 1996 Jul; 24(1):27-31. PubMed ID: 8707274
[TBL] [Abstract][Full Text] [Related]
29. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
Xie J; OuYang K; Su T
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810
[TBL] [Abstract][Full Text] [Related]
30. [Serum fibrosis markers in diagnosing liver fibrosis].
Liu J; Wang JY; Lu Y
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of serum fibrosis markers in diagnosis of infantile hepatitis syndrome].
Deng WL; Xiong H; Wang LL; Zou XB
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1029-32. PubMed ID: 25344185
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.
Lesmana CR; Hasan I; Budihusodo U; Gani RA; Krisnuhoni E; Akbar N; Lesmana LA
J Dig Dis; 2009 Aug; 10(3):201-6. PubMed ID: 19659788
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
36. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
Zhu CL; Li WT; Li Y; Gao RT
J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
[TBL] [Abstract][Full Text] [Related]
40. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
